Patents

US 9926346 B2: Recombinant mycobacterium encoding a heparin-binding hemagglutinin (HBHA) fusion protein and uses thereof

Granted
2018-03-27
Filed
2012-04-16 application 14394689
Type
Utility · 17 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Recombinant Mycobacteria (rMyc) which contain sequences encoding a heparin-binding hemagglutinin (HBHA) fusion protein are provided, as are methods of making and using the rMyc and the fusion protein. The fusion protein includes an amino terminal mycobacterial antigen Ag85B leader peptide and transcription of the fusion protein is driven by an Ag85B promoter sequence. The recombinant fusion protein is produced in abundance by the rMyc, is post-translationally methylated, and is highly antigenic.

Source: PVGPATDIS, file of 2026-04-10 (ipg180327.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Aeras, LLC 2 patentsUS company or organizationRockville, MDAERAS Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and statePVGPATDIS, file of 2026-04-10
Institut National De La Sante Et De La Recherche Medicale (Inserm) 745 patentsForeign company or organizationParis, FRPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
John FulkersonSilver Spring, MD8PVGPATDIS, file of 2026-04-10
Michael BrennanRockville, MD3PVGPATDIS, file of 2026-04-10
Kamalakannan VelmuruganRockville, MD1PVGPATDIS, file of 2026-04-10
Camille LochtBrussels, BE26PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K14/35PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K39/04PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P31/06PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2017-07-20Assignment
Assignment of assignor's interest
LOCHT, CAMILLE signed 2017-05-23INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) PARIS43051/533ECORSEXC, file of 2026-09-25
2017-07-20Assignment
Assignment of assignor's interest
BRENNAN, MICHAEL signed 2017-05-11
VELMURUGAN, KAMALAKANNAN signed 2017-06-07
FULKERSON, JOHN signed 2017-06-12
AERAS GLOBAL TB VACCINE FOUNDATION ROCKVILLE, MD43051/184ECORSEXC, file of 2026-09-25
2016-12-27Name change
Change of name
AERAS GLOBAL TB VACCINE FOUNDATION signed 2011-03-10AERAS ROCKVILLE, MD41303/681PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.